Brandes Investment Partners LP Acquires 3,284 Shares of Cigna Group $CI

Brandes Investment Partners LP boosted its holdings in shares of Cigna Group (NYSE:CI) by 0.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 674,759 shares of the health services provider’s stock after acquiring an additional 3,284 shares during the quarter. Cigna Group comprises 2.0% of Brandes Investment Partners LP’s holdings, making the stock its 10th largest holding. Brandes Investment Partners LP owned approximately 0.25% of Cigna Group worth $223,066,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CI. Financial Network Wealth Advisors LLC increased its position in shares of Cigna Group by 26.8% during the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after purchasing an additional 34 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in Cigna Group by 1.0% during the second quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock worth $1,137,000 after buying an additional 35 shares during the period. NDVR Inc. boosted its stake in Cigna Group by 5.0% during the second quarter. NDVR Inc. now owns 779 shares of the health services provider’s stock worth $258,000 after buying an additional 37 shares during the period. HBK Sorce Advisory LLC increased its position in shares of Cigna Group by 3.1% during the second quarter. HBK Sorce Advisory LLC now owns 1,263 shares of the health services provider’s stock valued at $418,000 after acquiring an additional 38 shares during the last quarter. Finally, Legacy Financial Advisors Inc. raised its stake in shares of Cigna Group by 2.9% in the 1st quarter. Legacy Financial Advisors Inc. now owns 1,400 shares of the health services provider’s stock valued at $461,000 after acquiring an additional 39 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a research report on Thursday, August 14th. TD Cowen lowered their price target on Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Cantor Fitzgerald dropped their price objective on Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. Guggenheim decreased their target price on Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $334.05.

Insider Activity at Cigna Group

In related news, CEO David Cordani bought 4,134 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $273.70 on Tuesday. The company has a market cap of $73.11 billion, a P/E ratio of 14.94, a PEG ratio of 0.88 and a beta of 0.44. The firm has a fifty day moving average price of $284.69 and a 200 day moving average price of $297.02. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The company had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period last year, the firm earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.